Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SAR-441566 by Sanofi for Rheumatoid Arthritis: Likelihood of Approval
SAR-441566 is under clinical development by Sanofi and currently in Phase II for Rheumatoid Arthritis. According to GlobalData, Phase II...
SAR-441566 by Sanofi for Inflammatory Bowel Disease: Likelihood of Approval
SAR-441566 is under clinical development by Sanofi and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData, Phase...
SAR-441566 by Sanofi for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
SAR-441566 is under clinical development by Sanofi and currently in Phase II for Plaque Psoriasis (Psoriasis Vulgaris). According to GlobalData,...
Risk adjusted net present value: What is the current valuation of Sanofi's SAR-441566?
SAR-441566 is a small molecule commercialized by Sanofi, with a leading Phase II program in Rheumatoid Arthritis. According to Globaldata,...